These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34987522)

  • 1. Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.
    Zghaebi M; Byazrova M; Flicker S; Villazala-Merino S; Campion NJ; Stanek V; Tu A; Breiteneder H; Filatov A; Khaitov M; Niederberger-Leppin V; Eckl-Dorna J; Valenta R
    Front Immunol; 2021; 12():803236. PubMed ID: 34987522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis.
    Wong KJ; Timbrell V; Xi Y; Upham JW; Collins AM; Davies JM
    Allergy; 2015 Apr; 70(4):420-8. PubMed ID: 25556717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.
    Selb R; Eckl-Dorna J; Neunkirchner A; Schmetterer K; Marth K; Gamper J; Jahn-Schmid B; Pickl WF; Valenta R; Niederberger V
    J Allergy Clin Immunol; 2017 Jan; 139(1):290-299.e4. PubMed ID: 27372566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
    Reginald K; Eckl-Dorna J; Zafred D; Focke-Tejkl M; Lupinek C; Niederberger V; Keller W; Valenta R
    Immunol Cell Biol; 2013 Feb; 91(2):167-72. PubMed ID: 23229638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.
    Klunker S; Saggar LR; Seyfert-Margolis V; Asare AL; Casale TB; Durham SR; Francis JN;
    J Allergy Clin Immunol; 2007 Sep; 120(3):688-95. PubMed ID: 17631952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation.
    Villazala-Merino S; Rodriguez-Dominguez A; Stanek V; Campion NJ; Gattinger P; Hofer G; Froeschl R; Fae I; Lupinek C; Vrtala S; Breiteneder H; Keller W; Perkmann T; Nakamura R; Pickl WF; Valenta R; Eckl-Dorna J; Niederberger V
    J Allergy Clin Immunol; 2020 Mar; 145(3):958-967.e5. PubMed ID: 31775017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.
    Eckl-Dorna J; Fröschl R; Lupinek C; Kiss R; Gattinger P; Marth K; Campana R; Mittermann I; Blatt K; Valent P; Selb R; Mayer A; Gangl K; Steiner I; Gamper J; Perkmann T; Zieglmayer P; Gevaert P; Valenta R; Niederberger V
    Allergy; 2018 May; 73(5):1003-1012. PubMed ID: 29083477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
    Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U
    J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-induced changes of B-cell phenotypes in patients with allergic rhinitis.
    Davidsson A; Karlsson MG; Hellquist HB
    Rhinology; 1994 Dec; 32(4):184-90. PubMed ID: 7535471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
    Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan JH; Krauth MT; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
    Allergy; 2008 Jun; 63(6):695-702. PubMed ID: 18325077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunoglobulin E and immune inflammation: implications in allergic rhinitis.
    Poole JA; Rosenwasser LJ
    Curr Allergy Asthma Rep; 2005 May; 5(3):252-8. PubMed ID: 15842964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical and direct involvement of the CD23 stalk region in IgE binding.
    Selb R; Eckl-Dorna J; Twaroch TE; Lupinek C; Teufelberger A; Hofer G; Focke-Tejkl M; Gepp B; Linhart B; Breiteneder H; Ellinger A; Keller W; Roux KH; Valenta R; Niederberger V
    J Allergy Clin Immunol; 2017 Jan; 139(1):281-289.e5. PubMed ID: 27343203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
    Bush RK
    Treat Respir Med; 2004; 3(1):45-57. PubMed ID: 15174893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
    Asam C; Batista AL; Moraes AH; de Paula VS; Almeida FC; Aglas L; Kitzmüller C; Bohle B; Ebner C; Ferreira F; Wallner M; Valente AP
    Clin Exp Allergy; 2014 Aug; 44(8):1083-93. PubMed ID: 24979350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.